Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping

The assessment of negative symptoms in schizophrenia has advanced since the 2006 NIMH-MATRICS Consensus Statement, leading to the development of second-generation rating scales like the Brief Negative Symptom Scale and the Clinical Assessment Interview for Negative Symptoms. These scales address the...

Full description

Saved in:
Bibliographic Details
Main Authors: Armida Mucci, Stefan Leucht, Giulia M. Giordano, Luigi Giuliani, Sophia Wehr, Lucia Weigel, Silvana Galderisi
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/15/1/83
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588894105763840
author Armida Mucci
Stefan Leucht
Giulia M. Giordano
Luigi Giuliani
Sophia Wehr
Lucia Weigel
Silvana Galderisi
author_facet Armida Mucci
Stefan Leucht
Giulia M. Giordano
Luigi Giuliani
Sophia Wehr
Lucia Weigel
Silvana Galderisi
author_sort Armida Mucci
collection DOAJ
description The assessment of negative symptoms in schizophrenia has advanced since the 2006 NIMH-MATRICS Consensus Statement, leading to the development of second-generation rating scales like the Brief Negative Symptom Scale and the Clinical Assessment Interview for Negative Symptoms. These scales address the limitations of first-generation tools, such as the inclusion of aspects that are not negative symptoms and the lack of assessment of the subject’s internal experience. However, psychometric validation of these scales is still in progress, and they are not yet recommended by regulatory agencies, thus limiting their use in clinical trials and settings. Complementing these traditional methods, remote digital phenotyping offers a novel approach by leveraging smartphones and wearable technology to capture real-time, high-resolution clinical data. Despite the potential to overcome traditional assessment barriers, challenges remain in aligning these digital measures with clinical ratings and ensuring data security. Equally important is patient acceptance, as the success of remote digital phenotyping relies on the willingness of patients to use these technologies. This review provides a critical overview of both second-generation scales and remote digital phenotyping for assessing negative symptoms, highlighting future research needs.
format Article
id doaj-art-320c2f30f11047f685ff42dacadd1840
institution Kabale University
issn 2076-3425
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj-art-320c2f30f11047f685ff42dacadd18402025-01-24T13:25:55ZengMDPI AGBrain Sciences2076-34252025-01-011518310.3390/brainsci15010083Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital PhenotypingArmida Mucci0Stefan Leucht1Giulia M. Giordano2Luigi Giuliani3Sophia Wehr4Lucia Weigel5Silvana Galderisi6Department of Mental and Physical Health and Preventive Medicine, School of Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie 1, 80135 Naples, ItalyDepartment of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum Rechts der Isar, Ismaningerstrasse 22, 81675 Munich, GermanyDepartment of Mental and Physical Health and Preventive Medicine, School of Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie 1, 80135 Naples, ItalyDepartment of Mental and Physical Health and Preventive Medicine, School of Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie 1, 80135 Naples, ItalyDepartment of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum Rechts der Isar, Ismaningerstrasse 22, 81675 Munich, GermanyDepartment of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum Rechts der Isar, Ismaningerstrasse 22, 81675 Munich, GermanyDepartment of Mental and Physical Health and Preventive Medicine, School of Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie 1, 80135 Naples, ItalyThe assessment of negative symptoms in schizophrenia has advanced since the 2006 NIMH-MATRICS Consensus Statement, leading to the development of second-generation rating scales like the Brief Negative Symptom Scale and the Clinical Assessment Interview for Negative Symptoms. These scales address the limitations of first-generation tools, such as the inclusion of aspects that are not negative symptoms and the lack of assessment of the subject’s internal experience. However, psychometric validation of these scales is still in progress, and they are not yet recommended by regulatory agencies, thus limiting their use in clinical trials and settings. Complementing these traditional methods, remote digital phenotyping offers a novel approach by leveraging smartphones and wearable technology to capture real-time, high-resolution clinical data. Despite the potential to overcome traditional assessment barriers, challenges remain in aligning these digital measures with clinical ratings and ensuring data security. Equally important is patient acceptance, as the success of remote digital phenotyping relies on the willingness of patients to use these technologies. This review provides a critical overview of both second-generation scales and remote digital phenotyping for assessing negative symptoms, highlighting future research needs.https://www.mdpi.com/2076-3425/15/1/83negative symptomsBNSSCAINSdigital phenotypingEMA
spellingShingle Armida Mucci
Stefan Leucht
Giulia M. Giordano
Luigi Giuliani
Sophia Wehr
Lucia Weigel
Silvana Galderisi
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
Brain Sciences
negative symptoms
BNSS
CAINS
digital phenotyping
EMA
title Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
title_full Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
title_fullStr Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
title_full_unstemmed Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
title_short Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
title_sort assessment of negative symptoms in schizophrenia from the consensus conference derived scales to remote digital phenotyping
topic negative symptoms
BNSS
CAINS
digital phenotyping
EMA
url https://www.mdpi.com/2076-3425/15/1/83
work_keys_str_mv AT armidamucci assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT stefanleucht assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT giuliamgiordano assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT luigigiuliani assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT sophiawehr assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT luciaweigel assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping
AT silvanagalderisi assessmentofnegativesymptomsinschizophreniafromtheconsensusconferencederivedscalestoremotedigitalphenotyping